Regulatory Advantage RightBio Metrics has an FDA-cleared and CLIA-waived RightSpotpH Indicator for confirming NG/OG tube placement, presenting a strong credibility signal for hospitals seeking compliant and safe bedside confirmation tools.

Clinical Focus Targeting neonatal, pediatric, and adult patient safety with a pH-based confirmation approach positions the company to appeal to multidisciplinary care teams, nurses, and tube-placement specialists in hospitals and NICUs.

Healthcare Events Active participation in ASPEN and SPN conferences provides direct access to nutrition support and pediatric nursing decision-makers, offering opportunities for product demonstrations, trials, and partnerships.

Low Revenue, High Growth Potential Current revenue under $1M but with differentiated, cost-saving technology and a clear clinical impact narrative, presenting scalable upsell opportunities within larger hospital systems and networks.

Technology & Integration Existing tech stack and e-commerce capabilities (Shopify, MySQL, WordPress) support streamlined procurement integration, potential for direct hospital purchases, and scalable marketing automation to drive adoption.